Importantly, the number of cases per surgeon per year in our institution had a three-fold increase between 2000 and 2022 (data not shown), mirroring the national and international increase in prostate cancer incidence after the introduction of PSA-analysis. This evidence concerns the gene KLK3 and prostate carcinoma.